Skip to main content Back to Top
Advertisement

11/20/2019

Nicardipine Hydrochloride Injection

Products Affected - Description

    • Cardene injection, Chiesi, 20 mg/200 mL in 0.9% sodium chloride, premixed bag, 10 count, NDC 10122-0313-10
    • Cardene injection, Chiesi, 20 mg/200 mL in 5% dextrose, premixed bag, 10 count, NDC 10122-0314-10
    • Cardene injection, Chiesi, 40 mg/200 mL in 5% dextrose, premixed bag, 10 count, NDC 24477-0324-02 - discontinued

Reason for the Shortage

    • Hikma has nicardipine vials available.
    • Mylan discontinued nicardipine vials.
    • Sun Pharma discontinued nicardipine ampules.
    • Chiesi did not provide a reason for the shortage.
    • Chiesi discontinued Cardene 40 mg/200 mL in 5% dextrose premixed bags in mid-2019.

Available Products

    • Cardene injection, Chiesi, 40 mg/200 mL in 0.9% sodium chloride, premixed bag, NDC 10122-0325-10
    • Nicardipine Hydrochloride injection, Hikma, 2.5 mg/mL, 10 mL vial, 10 count, NDC 00143-9689-10

Estimated Resupply Dates

    • Chiesi has Cardene IV 20 mg/200 mL in 5% dextrose and 0.9% sodium chloride premixed bags on back order and the company cannot estimate a release date.

Updated

Updated November 20, 2019 by Leslie Jensen, PharmD, Drug Information Specialist. Created June 13, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins